Summary: In the first half of my interview with Vas Narasimhan, CEO of Novartis, we discuss what Reimagining Medicine means in an R&D based company that is deeply committed to innovation; addressing the needs of the 2 billion people with no access to health care; and the potential for, and challenges of, radically improving patient outcomes with advanced therapies.
